Diabetic ketoacidosis associated with aripiprazole
Authors:
- 13 September 2005
- journal article
- case report
- Published by Wiley in Diabetic Medicine
- Vol. 22 (10) , 1440-1443
Abstract
Background Atypical antipsychotics have become the mainstay of management of schizophrenia and other psychotic disorders due to low risk of extrapyramidal symptoms. However, postmarketing data has reported atypical antipsychotic agents being associated with hyperglycaemia and diabetic ketoacidosis (DKA). We believe this to be the first published report of hyperglycaemia and DKA with the newest atypical antipsychotic agent, aripiprazole.Case report A 34‐year‐old African‐American female with schizophrenia presented to the emergency department with nausea, vomiting, and malaise for 3–4 days shortly after initiation of aripiprazole therapy. Initial laboratory results revealed significant hyperglycaemia with metabolic acidosis. The patient received treatment for DKA with an intravenous insulin infusion and fluid replacement. Isophane insulin suspension (NPH insulin) was begun immediately following the insulin drip and continued upon discharge from the hospital. Outpatient follow‐up information was not available.Conclusion To our knowledge, this is the first case report of aripiprazole associated with hyperglycaemia and DKA. This case is striking in that DKA occurred 4 days following initiation of aripiprazole and the patient had rapid resolution of symptoms and normalization of laboratory values upon discontinuation of aripiprazole. It is important that health‐care providers monitor for hyperglycaemia when prescribing atypical antipsychotics including aripiprazole.Keywords
This publication has 26 references indexed in Scilit:
- Consensus Development Conference on Antipsychotic Drugs and Obesity and DiabetesDiabetes Care, 2004
- Fatal Olanzapine-Induced KetoacidosisAmerican Journal of Psychiatry, 2003
- Diabetic Ketoacidosis in a Patient Treated with Olanzapine, Valproic Acid, and VenlafaxineSouthern Medical Journal, 2003
- Near Fatal Ketoacidosis With Olanzapine TreatmentPsychosomatics, 2002
- Simultaneous side effects of both clozapine and valproateIntensive Care Medicine, 2001
- New-Onset Diabetes Mellitus and Diabetic Ketoacidosis Associated With Olanzapine TreatmentPsychosomatics, 1999
- Clozapine-Induced Diabetic KetoacidosisAustralian & New Zealand Journal of Psychiatry, 1999
- Diabetic ketoacidosis and clozapinePostgraduate Medical Journal, 1998
- Clozapine and Associated Diabetes MellitusThe Journal of Clinical Psychiatry, 1997
- Ketoacidosis as a side‐effect of clozapine: a case reportActa Psychiatrica Scandinavica, 1996